drugset / Trial / NCT00003044

Chemotherapy in Treating Patients With Liver Cancer

NCT00003044 ↗

Phase 2 Unknown 55 enrolled Matrix Pharmaceutical
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving drugs in different ways may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of cisplatin and epinephrine administered directly into the tumor in treating patients who have primary liver cancer that cannot be removed during surgery.

Timeline

Start
1996-09
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject cisplatin-e therapeutic implant Unknown — Other